Upgrade to SI Premium - Free Trial

Wedbush Cuts Price Target to $66 on Cepheid (CPHD) Following 2Q15

July 24, 2015 10:13 AM
Wedbush reiterated an Outperform rating on Cepheid (NASDAQ: CPHD), and cut the price target to $66.00 (from $67.00), following 2Q15 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles